About

Bio

Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. The journal is dedicated to publishing important peer-reviewed research and cutting-edge reviews and commentaries promoting genetics, medicine, and biotechnology.

Email

email@cision.one

Website

site@cision.one

Social media

linkedin x facebook reddit

Location

United States of America

Frequency

upgrade

Circulation

upgrade

Sectors

Biotechnology, Diseases & Conditions, Genetics, Medicine, Specialised Medicine


Is this you? We'd love to hear from you, contact our journalist team.
Contact us to unlock the full profile

Most recent articles by Molecular Therapy

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet
Contact us to explore recent articles

Explore outlets similar to Molecular Therapy

  • STAT News
    STAT News

    Covers the frontiers of health and medicine including science labs, hospitals, biotechnology board rooms, and political back rooms. Hosted by The Boston Globe, STAT launched on November 5, 2015.

    View
  • Medscape
    Medscape

    Medscape was created for medical specialists, primary care physicians, and health professionals and offers medical news, clinical trial information, review articles, journal commentary, expert columns, patient education articles and book reviews. It also includes Web-based services for verifying insurance information, Medline and other search engines, as well as a physician directory enabling users to find physicians by practice, location or specialty.

    View
  • Scientific American
    Scientific American

    Established in 1845, Scientific American remains the oldest continuously-published magazine in the United States. Redesigned in October 2010, the publication covers the most important and exciting research in science, health, technology, the environment, and society, exploring important ideas often months and years before other media recognizes their importance. The magazine publishes 15 foreign language editions, and regular sections include Forum, which provides a platform for external experts to comment on science policy; Science Agenda, where editors can discuss different science issues; and Insights, which profiles a scientist or researcher and analyzes their contribution to society. Other sections include Anti Gravity and Skeptic. Regular columns include The Science of Health and TechnoFiles. Publicists should feel free to pitch anytime, although they should avoid pitching individual products or new company officer announcements. They should focus on science-based stories that are better told by a journalist than an expert.

    View
  • The BMJ
    The BMJ

    The British Medical Journal publishes papers on research, education, news & views and campaigns provided they have not been published elsewhere and/or do not overlap substantially with other published material. Papers include research, randomised controlled trials on open peer review, peer review training guidelines and clinical trials results. The British Medical Journal is published on behalf of the British Medical Association. The journal is distributed to hospital clinicians, GPs, academics and an international audience.  Impact Factor: 20.7  Journal ranking: 375 (Scimago Journal & Country Rank) Manuscript Submission: Author guidlines: www.bmj.com/about-bmj/resources-authors

    View
  • J
    JAMA

    Established in 1883 and published as an international, peer-reviewed, general medical journal distributed to readers in more than 148 countries. Covers all subjects that relate to the practice of medicine and the betterment of public health worldwide. Editorial content contains original contributions covering randomized controlled trials, intervention studies, studies of screening and diagnostic tests, outcome studies, case control series and surveys with high response rates. Includes systematic, critical assessments of literature and data sources pertaining to clinical topics, brief reports of original studies or evaluation and letters discussing recent articles. Also includes book, journal and new media reviews, as well as editorials, abstracts and reference directories.

    View
Use CisionOne to find more relevant outlets

Contact Molecular Therapy and get access to over 850K accurate, up-to-date media profiles.

Discover the stories that impact your brand. In realtime.

CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.